“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

the specialist US firm choosing to launch its first-in-class cystic fibrosis drug Kalydeco around the world without a big pharma partner. Sarah Rickwood says existing top 20 companies need to keep ...

While this will benefit MNC pharma companies, the government should have ... India's youth for the "Make in India, Make for the World" initiative. Alongside 10,000 fellowships for IITs and Indian ...

Academics and pharma executives ... projects or companies fail. Only a tiny few biotech innovations will become globally impactful successes. Further, it can take 10-20 years for innovations ...

The team behind moxidectin – not-for-profit pharma company ... among the poorest in the world, which means they are unattractive customers for pharmaceutical companies. Moxidectin treats river ...

India's pharmaceutical industry is set to grow significantly, with its share in the global market expected to reach 5% by 2030. Currently valued at USD 55 billion, the market is projected to hit up to ...

Ajanta has been consistently providing affordable and quality medicines to patients in different parts of the world ... Ajanta Pharma was ranked among the Top 10 pharma companies in Franco ...